Natalizumab Active Not Recruiting Phase 1 Trials for Inclusion Body Myositis (IBM) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02483845Natalizumab in Inclusion Body Myositis (IBM)